Skip to main content
. 2021 Oct 17;13(20):5206. doi: 10.3390/cancers13205206
RT radiation therapy
OP oropharynx
RFS relapse-free survival
OS overall survival
PFS progression-free survival
ORR overall response rate
LRF locoregional failure
IC induction chemotherapy
CRT chemoradiotherapy
ISH in situ hybridization
IHC immunohistochemistry
Fx fractions
Gy Gray
BID twice a day
AUC area under the curve
MDADI MD Anderson Dysphagia Inventory
PORT post-operative radiation therapy
POCRT post-operative chemoradiotherapy
IMRT intensity modulated radiation therapy
QoL quality of life
SFX standard fraction